Análisis Argos
HUM
HUMCara
Humana Inc. · Healthcare
US$ 388.71
precio al 2026-07-28
Valor justo Argos*
US$ 258–283
vs. su valor justo
38% por encima
Score Argos
31/100
LA RESPUESTA
El mercado le pide crezca 14.9% al año — más de lo que ha demostrado (3.6%). Estás pagando un futuro que todavía no probó: el margen de error es mínimo.
Recompensas
Sin recompensas destacadas.
Riesgos
!El precio pide más crecimiento del que la empresa ha demostrado.
!Balance frágil: la deuda pesa sobre el negocio.
VALOR2/6FUTURO3/6PASADO2/6SALUD1/6DIVIDENDO2/6
El Iris de calidad
VALOR2/6FUTURO3/6PASADO2/6SALUD1/6DIVIDENDO2/6
ValorCerca de su valor justo
FuturoCrecimiento moderado
PasadoHistorial aceptable
SaludBalance frágil
DividendoRetorno al accionista moderado
Score Argos31de 100Cara
Ingresos10%
US$ 129.7 B
Margen operativo21%
1.1%
Flujo de caja libre84%
US$ 0.4 B
Deuda neta
US$ 8.7 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 46.7B
P/E39.3x
EV/EBITDA24.3x
FCF yield0.8%
ROIC4.6%
Margen operativo1.1%
Crecim. ingresos+10.1%/año
Piotroski F5/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

zacks.com · 17 jul
Is Humana (HUM) Stock Outpacing Its Medical Peers This Year?
Here is how Humana (HUM) and Envoy Medical, Inc. (COCH) have performed compared to their sector so far this year.
zacks.com · 16 jul
Can Humana (HUM) Run Higher on Rising Earnings Estimates?
Humana (HUM) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
benzinga.com · 16 jul
Medicare's $50 Weight-Loss Drug Window Opens In July: What Smart Enrollees Do Before 2027
A weight-loss prescription that runs $149 to $449 a month at the pharmacy counter now costs some Medicare enrollees $50. Across a year, that is the difference between roughly $600 and more than $4,000, and whether you capture the savings depends on a coverage question most people do not realize they are answering.
zacks.com · 13 jul
Humana Eyes 3% Medicare Advantage Margin: Can It Deliver?
Humana targets a 3% Medicare Advantage margin by 2028 while pursuing 25% 2026 membership growth and rebuilding profitability despite industry headwinds.
gurufocus.com · 3 jul
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, July 3, 2026
prnewswire.com · 3 jul
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
businesswire.com · 30 jun
The Humana Foundation Deepens Investment in Emotional Health, Announcing Over $12 Million in New Grants
LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 45 years, today announced its first slate of 2026 grants, dedicating over $12.2 million to programs and research focused on emotional well-being. The funding will support 13 nonprofit organizations and five university research teams focused on combating loneliness, depression and social isolation among seniors and veterans nationwide. The 2026 national grants scale the Foundati.
prnewswire.com · 30 jun
Dario Appoints Former Humana Chief Compliance Officer Sean O'Reilly to Advisory Board to Support Strategic Growth and Healthcare Partnerships
O'Reilly's extensive experience across healthcare compliance, risk management, regulatory oversight and payer operations expected to support Dario's continued expansion with health plans, employers and providers as Dario moves closer to care O'Reilly's track record of leveraging advanced data analytics and AI in supporting value-based care strongly aligned with Dario's AI transition NEW YORK, June 30, 2026 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leader in AI-enabled digital health solutions, today announced the appointment of Sean O'Reilly to its Advisory Board. The appointment reflects Dario's continued focus on strengthening its strategic guidance as the Company advances its channel partner-led growth strategy and moves closer to care across the payer, provider and employer markets.

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.